Rigaku Announces New Tagline ~POWERING NEW PERSPECTIVES~
September 15, 2022
Rigaku Corporation (Head Office: Akishima, Tokyo; President: Toshiyuki Ikeda; hereafter "Rigaku"), a leading manufacturer of X-ray analysis and inspection equipment, announces that it has launched a new slogan and a fresh approach to the market after 70 years of bringing innovation to the global scientific community. Since its founding, Rigaku, together with its group companies [...]
Sekkei Bio Implements CDD Vault to Centralize Research Data
September 15, 2022
San Francisco and Bangalore — Collaborative Drug Discovery (CDD) announced today that Sekkei Bio, an India-based company dedicated to building cutting-edge technologies for drug and vaccine design with global impact, has implemented CDD Vault as the main platform to house its research data. Sekkei has made big progress toward finding therapies for diabetes and pain. Sekkei Bio [...]
September 15, 2022
ViQi, Inc, a California cloud-based image analysis company specializing in using artificial intelligence for the scientific discovery process, is excited to announce the appointment of Pascal Bamford, Ph.D. to the board of directors and Timothy Spicer, Ph.D. as the inaugural member of the scientific advisory board. SANTA BARBARA, Calif. - ViQi, Inc, a California cloud-based image analysis company specializing [...]
September 15, 2022
BOSTON, Mass. – TetraScience, the Scientific Data Cloud company, announced today that AgiLab, provider of a unified laboratory digital platform, has joined the Tetra Partner Network to help biopharmaceutical customers accelerate R&D efficiency and maximize quality control processes with the Tetra Scientific Data Cloud(™). “We’re delighted to partner with AgiLab, who share our commitment to maximize [...]
September 15, 2022
Opportunity to provide digital data and decentralized trial services for multi-institutional cancer trials led by NCI-supported organizations WILMINGTON, N.C. -- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of [...]
Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight
September 15, 2022
Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfully completed extended concordance testing on Olink’s platforms (Olink® Target 48/96 and Olink® Explore), fulfilling specific requirements that supplement the Olink quality acceptance criteria. This latest validation was initiated by and implemented in cooperation with a leading global [...]
ZEISS microscope developers nominated for 2022 German Future Prize
September 14, 2022
ZEISS Lattice Lightsheet 7 enables the gentle 3D imaging of living cells Jena / Munich, Germany -- Today, the Office of the Federal President announced the nominations for the German Future Prize (Deutscher Zukunftspreis) at the German Museum in Munich. ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for [...]
September 14, 2022
Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN’s NGS testing portfolio for precision medicine beyond oncology into neurology applications HILDEN, Germany & GERMANTOWN Md. & SOUTH SAN FRANCISCO, Calif. -- QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc., an early stage [...]
September 14, 2022
Paris - GTT announces it has taken a minority stake in the Norwegian technology start-up Tunable AS, via a €6.4 million investment round co-led with TRUMPF Venture, with the participation of the company's existing shareholders. Tunable AS designs and manufactures compact multi-gas analysers based on MEMS[1] technology, combining micro and nanotechnology with infrared spectroscopy[2]. The sensors developed [...]
Gemini BioProducts Announces Addition to Board of Directors
September 14, 2022
Cory Stevenson, former President of the BioProduction division at Thermo Fisher Scientific joins Board FORT LAUDERDALE, Fla and SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson to its Board of Directors. [...]

